Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SOCIETE D'EXPLOITATION DU SERVICE DE CARDIOLOGIE INTERVENTIONNELLE DE LA CLINIQUE BERGOUIGNAN : revenue, balance sheet and financial ratios

SOCIETE D'EXPLOITATION DU SERVICE DE CARDIOLOGIE INTERVENTIONNELLE DE LA CLINIQUE BERGOUIGNAN is a French company founded 26 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in EVREUX (27000), this company of category PME shows in 2024 a net income positive of 6 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SOCIETE D'EXPLOITATION DU SERVICE DE CARDIOLOGIE INTERVENTIONNELLE DE LA CLINIQUE BERGOUIGNAN (SIREN 423613777)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net income 6 054 € 43 967 € 33 420 € 33 532 € 41 455 € 25 504 € 32 714 € 34 548 € 30 432 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, SOCIETE D'EXPLOITATION DU SERVICE DE CARDIOLOGIE INTERVENTIONNELLE DE LA CLINIQUE BERGOUIGNAN generates positive net income of 6 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 30 k€ -> 6 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

6 054 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 1%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 59%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

1.457%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

59.057%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

24.3%

Solvency indicators evolution
SOCIETE D'EXPLOITATION DU SERVICE DE CARDIOLOGIE INTERVENTIONNELLE DE LA CLINIQUE BERGOUIGNAN

Sector positioning

Debt ratio
1.46 2024
2022
2023
2024
Q1: 0.0
Med: 4.27
Q3: 43.96
Good -5 pts over 3 years

In 2024, the debt ratio of SOCIETE D'EXPLOITATION DU... (1.46) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
59.06% 2024
2022
2023
2024
Q1: 14.64%
Med: 38.36%
Q3: 60.56%
Good

In 2024, the financial autonomy of SOCIETE D'EXPLOITATION DU... (59.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 187.84. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

187.84

Liquidity indicators evolution
SOCIETE D'EXPLOITATION DU SERVICE DE CARDIOLOGIE INTERVENTIONNELLE DE LA CLINIQUE BERGOUIGNAN

Sector positioning

Liquidity ratio
187.84 2024
2022
2023
2024
Q1: 132.74
Med: 202.27
Q3: 325.9
Average +13 pts over 3 years

In 2024, the liquidity ratio of SOCIETE D'EXPLOITATION DU... (187.84) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positioning of SOCIETE D'EXPLOITATION DU SERVICE DE CARDIOLOGIE INTERVENTIONNELLE DE LA CLINIQUE BERGOUIGNAN in its sector

Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Valuation estimate

Based on 124 transactions of similar company sales (all years), the value of SOCIETE D'EXPLOITATION DU SERVICE DE CARDIOLOGIE INTERVENTIONNELLE DE LA CLINIQUE BERGOUIGNAN is estimated at 4 973 € (range 1 892€ - 18 162€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
124 transactions
1k€ 4k€ 18k€
4 973 € Range: 1 892€ - 18 162€
NAF 5 all-time

Valuation method used

Net Income Multiple
6 054 € × 0.8x = 4 973 €
Range: 1 893€ - 18 162€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)

Compare SOCIETE D'EXPLOITATION DU SERVICE DE CARDIOLOGIE INTERVENTIONNELLE DE LA CLINIQUE BERGOUIGNAN with other companies in the same sector:

Frequently asked questions about SOCIETE D'EXPLOITATION DU SERVICE DE CARDIOLOGIE INTERVENTIONNELLE DE LA CLINIQUE BERGOUIGNAN

What is the revenue of SOCIETE D'EXPLOITATION DU SERVICE DE CARDIOLOGIE INTERVENTIONNELLE DE LA CLINIQUE BERGOUIGNAN ?

The revenue of SOCIETE D'EXPLOITATION DU SERVICE DE CARDIOLOGIE INTERVENTIONNELLE DE LA CLINIQUE BERGOUIGNAN is not publicly disclosed (confidential accounts filed with INPI).

Is SOCIETE D'EXPLOITATION DU SERVICE DE CARDIOLOGIE INTERVENTIONNELLE DE LA CLINIQUE BERGOUIGNAN profitable?

Yes, SOCIETE D'EXPLOITATION DU SERVICE DE CARDIOLOGIE INTERVENTIONNELLE DE LA CLINIQUE BERGOUIGNAN generated a net profit of 6 k€ in 2024.

Where is the headquarters of SOCIETE D'EXPLOITATION DU SERVICE DE CARDIOLOGIE INTERVENTIONNELLE DE LA CLINIQUE BERGOUIGNAN ?

The headquarters of SOCIETE D'EXPLOITATION DU SERVICE DE CARDIOLOGIE INTERVENTIONNELLE DE LA CLINIQUE BERGOUIGNAN is located in EVREUX (27000), in the department Eure.

Where to find the tax return of SOCIETE D'EXPLOITATION DU SERVICE DE CARDIOLOGIE INTERVENTIONNELLE DE LA CLINIQUE BERGOUIGNAN ?

The tax return of SOCIETE D'EXPLOITATION DU SERVICE DE CARDIOLOGIE INTERVENTIONNELLE DE LA CLINIQUE BERGOUIGNAN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SOCIETE D'EXPLOITATION DU SERVICE DE CARDIOLOGIE INTERVENTIONNELLE DE LA CLINIQUE BERGOUIGNAN operate?

SOCIETE D'EXPLOITATION DU SERVICE DE CARDIOLOGIE INTERVENTIONNELLE DE LA CLINIQUE BERGOUIGNAN operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.